Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials — Arturo Cesaro (2025) | RDL Network
Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials
Article 2025 en
Authors
AC
Arturo Cesaro
DP
Daniele Pastori
VA
Vincenzo Acerbo
Abstract
1 min read
Treatment with semaglutide significantly reduces the incidence of new-onset AF. This effect appears more evident with the oral formulation and independent of baseline characteristics.
Marco Borgi, Marco Proietti, Giulio Francesco Romiti, Marco Vitolo, Arianna Di Rocco, Alessio Farcomeni, Kazuo Miyazawa, Jeff S. Healey, Deirdre A. Lane, Giuseppe Boriani, Stefania Basili, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.